Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Held

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Circulation|April 12, 2024
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management EraFelix Gerhardt, Eva Fiessler, Karen M Olsson, et al.
International Journal of Cardiology|September 10, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018Heinrike Wilkens, Stavros Konstantinides, Irene M Lang, et al.
The European Respiratory Journal|April 4, 2015
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registryJürgen Behr, Michael Kreuter, Marius M Hoeper, et al.
The Lancet. Respiratory Medicine|April 2, 2021
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trialJürgen Behr, Antje Prasse, Michael Kreuter, et al.
Journal of Thrombosis and Thrombolysis|September 1, 2016
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort studyStavros V Konstantinides, Stefano Barco, Stephan Rosenkranz, et al.
Chest|February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
ERJ Open Research|January 15, 2025
Cost-effectiveness of follow-up algorithms for chronic thromboembolic pulmonary hypertension in pulmonary embolism survivorsDieuwke Luijten, Wilbert B van den Hout, Gudula J A M Boon, et al.
ERJ Open Research|January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysisJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Circulation|April 12, 2024
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management EraFelix Gerhardt, Eva Fiessler, Karen M Olsson, et al.
International Journal of Cardiology|September 10, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018Heinrike Wilkens, Stavros Konstantinides, Irene M Lang, et al.
The European Respiratory Journal|April 4, 2015
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registryJürgen Behr, Michael Kreuter, Marius M Hoeper, et al.
The Lancet. Respiratory Medicine|April 2, 2021
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trialJürgen Behr, Antje Prasse, Michael Kreuter, et al.
Journal of Thrombosis and Thrombolysis|September 1, 2016
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort studyStavros V Konstantinides, Stefano Barco, Stephan Rosenkranz, et al.
Chest|February 13, 2021
Pulmonary Hypertension in Patients With COPD: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Carmine Dario Vizza, Marius M Hoeper, Doerte Huscher, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
ERJ Open Research|January 15, 2025
Cost-effectiveness of follow-up algorithms for chronic thromboembolic pulmonary hypertension in pulmonary embolism survivorsDieuwke Luijten, Wilbert B van den Hout, Gudula J A M Boon, et al.
ERJ Open Research|January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysisJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Circulation|October 2, 2013
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)Karen M Olsson, Marion Delcroix, H Ardeschir Ghofrani, et al.
Pageof 11